HHS reports increase in buprenorphine providers, naloxone prescriptions
The number of health care providers with waivers to prescribe buprenorphine for opioid use disorder increased 19% between October 2021 and September 2022 to 132,005, the Department of Health and Human Services announced today. HHS last April issued revised practice guidelines for administering buprenorphine to treat OUD, which eased requirements for clinicians to obtain a waiver to treat OUD patients with buprenorphine. According to HHS, pharmacy-filled prescriptions for the overdose reversal drug naloxone also increased 37% over the period, from a three-month average of 109,414 prescriptions in October 2021 to 150,213 in August 2022.
Related News Articles
Headline
The Centers for Medicare & Medicaid Services June 13 announced it approved state plan amendments to expand Medicaid access to care for tribal communities…
Headline
The departments of Health and Human Services, Labor, and the Treasury have certified two more independent dispute resolution entities, bringing the total…
Perspective
The fate of the Trump administration’s legislative centerpiece — the One Big Beautiful Bill Act — continues to be the focal point in Washington, D.C.After the…
Headline
The House June 4 passed the AHA-supported SUPPORT Act (H.R. 2483) by a 366-57 vote. The legislation reauthorizes key prevention, treatment and recovery…
Headline
The Department of Health and Human Services and Centers for Medicare & Medicaid Services said June 3 they are rescinding 2022 CMS guidance with the subject…
Headline
The Government Accountability Office May 29 released a report recommending the Centers for Medicare & Medicaid Services target behavioral health services…